Biomarkers Products & Reviews

Human Coronavirus 229E Nucleoprotein is a recombinant protein containing 359 amino acids derived from the nucleocapsid sequence, with a C-terminal 6xHis tag. It is manufactured in E. coli with greater than 95% purity.

Human Coronavirus NL63 Nucleoprotein is a recombinant protein containing the nucleocapsid C-terminal region (130 amino acids), cloned and expressed in E. coli, and purified by affinity chromatography (nickel column) with greater than 95% purity.

The Gyrolab® Mouse IFN-gamma Kit enables rapid quantification of murine IFN-gamma in serum samples

The Gyrolab® Mouse IL-6 Kit enables rapid quantification of murine IL-6 in serum samples

The Gyrolab® Mouse IL-10 Kit enables rapid quantification of murine IL-10 in serum samples

Gyrolab® Bioaffy™ 4000, the newest member of the Gyrolab Bioaffy family, offers 2-6 fold extended sensitivity for PK and biomarker analysis compared to Gyrolab Bioaffy 1000.

The Gyrolab® Mouse IL-4 Kit enables rapid quantification of murine IL-4 in serum samples

The Gyrolab® Mouse TNF-alpha Kit enables rapid quantification of murine TNF-alpha in serum samples

Gyrolab® Bioaffy™ 200, the most versatile disc in the Bioaffy range, with 112 data points and 200 nL sample volume this disc fits many different applications.

The Gyrolab® Human IL-10 Kit Reagents enables rapid quantification of IL-10 in human serum samples

The Gyrolab® Human IL-4 Kit Reagents enables rapid quantification of IL-4 in human or cyno serum samples

The Gyrolab® Human IL-6 Kit Reagents enables rapid quantification of IL-6 in human or cyno serum samples

The Gyrolab® Human IFN-gamma Kit Reagents enables rapid quantification of IFN-gamma in human or cyno serum samples

The Gyrolab® Human TNF-alpha Kit Reagents enables rapid quantification of TNF-alpha in human or cyno serum samples

IRDye® Click Chemistry reagents (DBCO, Alkyne, and Azide) offer convenient, versatile and reliable methods for biomolecule labeling. With a variety of in vitro and in vivo applications, from biomarker isolation to assay development.

Myelotracker® is a cutting-edge fluorescent probe that enables precise detection of neutrophils—essential immune cells—in both blood and tissue samples. It offers researchers a dependable tool for exploring inflammation, infections, and immune system activity.

Biomarker assay kits

Unleash the full power of a well-designed library. With Twist Bioscience, you are assured that the library you design contains the specific modifications, exactly where you want them, saving you valuable resources for the downstream screening process.

Twist Biopharma, a division of Twist Bioscience, provides services to help accelerate the way our partners discover and optimize antibody therapeutics with our unique DNA writing technology. Twist constructs proprietary antibody libraries precisely designed to match sequences that occur in the human body giving our partners an integral and unbiased resource for antibody therapeutic discovery and optimization.

Twist Biopharma, a division of Twist Bioscience, provides services to help accelerate the way our partners discover and optimize antibody therapeutics with our unique DNA writing technology. Twist constructs proprietary antibody libraries precisely designed to match sequences that occur in the human body giving our partners an integral and unbiased resource for antibody therapeutic discovery and optimization.

BioIVT has the expertise in the processes required for ethical acquisition of biospecimens that cover a wide range of disease states and the protocols needed to produce reliable data. With over 425 IRB-approved clinical sites, BioIVT provides clinical specimens for nearly all disease states.

BioIVT supplies high quality, ready to ship or custom plasma, serum, and whole blood—both normal and disease-state—collected from a diverse pool of consented donors under IRB-approved protocols or a wide variety of species.

As the world's largest private repository of human cerebrospinal fluid, BioIVT’s Center for NeuroExcellence offers 35,000+ healthy and 113,000+ diseased donor samples allowing for comparative studies and precise control matching. The samples are ethically collected following strict quality standards and feature detailed clinical data and matching blood, plasma, or sera.

Accelerating radiopharmaceutical development in oncology

Host response biomarker of sepsis risk